BAMIAS A ET AL: "Angiogenesis: a promising therapeutic target for ovarian cancer.", CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY DEC 2012, vol. 84, no. 3, December 2012 (2012-12-01), pages 314 - 326, XP002698499, ISSN: 1879-0461 (B1)

WRIGHT JASON D ET AL: "Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma: A retrospective analysis.", CANCER 1 JUL 2006, vol. 107, no. 1, 1 July 2006 (2006-07-01), pages 83 - 89, XP002698498, ISSN: 0008-543X (B1)

CLINICAL TRIALS IDENTIFIER : NCT00976911: "Aurelia: A study of Avastin (Bevacizumab) added to chemotherapy in patients with platinum-resistant ovarian cancer", 15 March 2011 (2011-03-15), Retrieved from the Internet <URL:clinicaltrials.gov> [retrieved on 20170612] (B1)

COHEN MARTIN H ET AL: "FDA drug approval summary: bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer.", THE ONCOLOGIST MAR 2007, vol. 12, no. 3, March 2007 (2007-03-01), pages 356 - 361, XP002712135, ISSN: 1083-7159 (B1)

COHN D E ET AL: "Bevacizumab and weekly taxane chemotherapy demonstrates activity in refractory ovarian cancer", GYNECOLOGIC ONCOLOGY, ACADEMIC PRESS, LONDON, GB, vol. 102, no. 2, 1 August 2006 (2006-08-01), pages 134 - 139, XP024921475, ISSN: 0090-8258, [retrieved on 20060801], DOI: 10.1016/J.YGYNO.2006.01.030 (B1)

D. M. O'MALLEY & AL: "Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer", GYNECOLOGIC ONCOLOGY, vol. 121, 1 January 2011 (2011-01-01), pages 269 - 272, XP028196737, DOI: 10.1016/j.ygyno.2011.01.009 (B1)

GERBER HANS-PETER ET AL: "Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 65, no. 3, 1 February 2005 (2005-02-01), pages 671 - 680, XP002481174, ISSN: 0008-5472 (B1)

J. A. LEDERMANN, F. A. RAJA: "Clinical trials and decision-making strategies for optimal treatment of relapsed ovarian cancer", EUROPEAN JOURNAL OF CANCER, vol. 47, no. 3, 1 September 2011 (2011-09-01), pages s104 - s115 (B1)

LORTHOLARY A ET AL: "Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from GINECO", ANNALS OF ONCOLOGY, vol. 23, 2012, pages 346 - 352, XP055687643, DOI: 10.1093/annonc/mdr149 (B1)

MCGONIGLE KATHRYN F ET AL: "Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: results of a phase 2 study.", CANCER 15 AUG 2011, vol. 117, no. 16, 15 August 2011 (2011-08-15), pages 3731 - 3740, XP002712134, ISSN: 1097-0142 (B1)

MONK B J ET AL: "Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer", GYNECOLOGIC ONCOLOGY, ACADEMIC PRESS, LONDON, GB, vol. 102, no. 2, 1 August 2006 (2006-08-01), pages 140 - 144, XP024921476, ISSN: 0090-8258, [retrieved on 20060801], DOI: 10.1016/J.YGYNO.2006.05.006 (B1)

RICHARDSON D L ET AL: "Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer", GYNECOLOGIC ONCOLOGY, ACADEMIC PRESS, LONDON, GB, vol. 111, no. 3, 1 December 2008 (2008-12-01), pages 461 - 466, XP025691004, ISSN: 0090-8258, [retrieved on 20080930], DOI: 10.1016/J.YGYNO.2008.08.011 (B1)

TSUNETOH SATOSHI ET AL: "Topotecan as a molecular targeting agent which blocks the Akt and VEGF cascade in platinum-resistant ovarian cancers.", CANCER BIOLOGY & THERAPY 1 DEC 2010, vol. 10, no. 11, 1 December 2010 (2010-12-01), pages 1137 - 1146, XP002712136, ISSN: 1555-8576 (B1)

US-A1- 2006 013 819 (B1)

US-A1- 2007 166 388 (B1)

WO-A1-2008/075330 (B1)

CHURA ET AL: "Bevacizumab plus cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer", GYNECOLOGIC ONCOLOGY, ACADEMIC PRESS, LONDON, GB, vol. 107, no. 2, 1 November 2007 (2007-11-01), pages 326 - 330, XP022350665, ISSN: 0090-8258, DOI: 10.1016/J.YGYNO.2007.07.017 (B1)